TABLE 1.
Parameter | C (N = 20) | BD patients (N = 20) | p-value |
---|---|---|---|
Age (years) | 48.80 ± 7.34 | 51.10 ± 9.85 | 0.408 a |
Gender (F/M) | 10/10 | 10/10 | - |
IGF-2 (ng/mL) | 114.53 ± 50.59 | 135.25 ± 64.02 | 0.478 b |
IGFBP-1 (ng/mL) | 8.17 ± 4.78 | 8.92 ± 4.06 | 0.597 a |
IGFBP-3 (ng/mL) | 474.33 ± 82.24 | 264.11 ± 60.22 | < 0.0001 a |
IGFBP-5 (ng/mL) | 82.46 ± 14.77 | 33.35 ± 13.06 | < 0.0001 a |
IGFBP-7 (ng/mL) | 70.09 ± 28.89 | 143.21 ± 130.69 | 0.165 b |
MCP-1 (pg/mL) | 72.31 ± 27.18 | 109.33 ± 73.92 | < 0.05 a |
MIP-1β (pg/mL) | 43.59 ± 23.66 | 80.52 ± 87.42 | 0.068 a |
TNF-α (pg/mL) | 36.01 ± 17.31 | 46.06 ± 24.64 | 0.150 a |
The p-value was calculated and is reported according to the APA style. The following tests were applied:
Unpaired Student’s t-test.
Mann–Whitney test.
C, control group; BD, bipolar disorder; IGF, insulin-like growth factor; IGFBP, insulin-like growth factor-binding protein; MCP-1, monocyte chemoattractant protein 1; MIP-1β, macrophage inflammatory protein 1 beta; TNF-α, tumor necrosis factor alpha.